Clinical trial
Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy
NCT00299533 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00299533 |
|---|---|
| Title | Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy |
| Official title | A Randomized, Double-blind, Placebo-controlled, Prospective Study Evaluating the Usefulness of Polyunsaturated Fatty Acids (PUFA) in Patients Wtih Uncontrolled Epilepsy |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | CURE Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Fish oil (Super Omega-3, 4 caps/d) vs. placebo |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Mar 7, 2006 |
| Last update posted | Aug 16, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: